FTSE 100: GSK tops forecasts after strong sales of shingles vaccine
Yahoo! Finance
GlaxoSmithKline has improved their forecasts for 2023 after results reveal strong sales of the pharmaceutical firm's shingles vaccine.
Continue Reading